(Q33183693)

23 July 2017

Enhancement of radiation therapy by the novel vascular targeting agent ZD6126. (English)

1 reference

23 July 2017

0 references

Dietmar W Siemann

1

1 reference

PubMed ID

12007956

23 July 2017

Amyn M Rojiani

series ordinal

2

1 reference

PubMed ID

12007956

23 July 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

International Journal of Radiation Oncology Biology Physics

23 July 2017

1 reference

23 July 2017

53

1 reference

23 July 2017

164-171

1 reference

23 July 2017

1

1 reference

Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis

23 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902742-6

7 January 2021

Angiogenesis in the pathobiology and treatment of vascular and malignant diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902742-6

7 January 2021

Endothelial proliferation in tumours and normal tissues: Continuous labelling studies

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902742-6

7 January 2021

Angiogenesis as a target for tumor treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902742-6

7 January 2021

Review article: angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902742-6

7 January 2021

Inhibition of growth of colon 38 adenocarcinoma by vinblastine and colchicine: evidence for a vascular mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902742-6

7 January 2021

Anti-vascular approaches to solid tumour therapy: evaluation of vinblastine and flavone acetic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902742-6

7 January 2021

Targeting the tumor vasculature with combretastatin A-4 disodium phosphate: effects on radiation therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902742-6

7 January 2021

In vivo and in vitro evaluation of combretastatin A-4 and its sodium phosphate prodrug

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902742-6

7 January 2021

Targeting tumor blood vessels: an adjuvant strategy for radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902742-6

7 January 2021

The effect of combretastatin A-4 disodium phosphate in a C3H mouse mammary carcinoma and a variety of murine spontaneous tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902742-6

7 January 2021

Antitumor effects due to irreversible stoppage of tumor tissue blood flow: evaluation of a novel combretastatin A-4 derivative, AC7700.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902742-6

7 January 2021

Interaction between combretastatin A-4 disodium phosphate and radiation in murine tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902742-6

7 January 2021

Radiobiological hypoxia in the KHT sarcoma: predictions using the Eppendorf histograph

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902742-6

7 January 2021

Validation of the fluorescent dye Hoechst 33342 as a vascular space marker in tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902742-6

7 January 2021

In vivo tumor response to single and multiple exposures of adriamycin

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902742-6

7 January 2021

Preclinical evaluations of therapies combining the vascular targeting agent combretastatin A-4 disodium phosphate and conventional anticancer therapies in the treatment of Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902742-6

7 January 2021

Tumor Infarction in Mice by Antibody-Directed Targeting of Tissue Factor to Tumor Vasculature

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902742-6

7 January 2021

10.1016/S0360-3016(02)02742-6

Identifiers

DOI

1 reference

23 July 2017

1 reference

PubMed ID

12007956